Association Between Myasthenia Gravis-Activities of Daily Living (MG-ADL) and EQ-5D-5L Utility Values: The Additional Effect of Efgartigimod on Utilities.
Sarah DewildeCynthia Z QiGlenn PhillipsSergio IannazzoMathieu F JanssenPublished in: Advances in therapy (2023)
Among patients with gMG, improvements in MG-ADL were significantly associated with higher utility values. MG-ADL scores alone were not sufficient to capture the utility gained from efgartigimod therapy.